 |
|
Fournier Gangrene in a Patient With Type 2 Diabetes Mellitus Treated With Dapagliflozin: A Case Report
Jae Young Moon, Min Ro Lee, Jong Hun Kim, Gi Won Ha
Ann Coloproctol. 2021;37(Suppl 1):S48-S50. Published online 2021 May 28 DOI: https://doi.org/10.3393/ac.2020.06.22
|
|
Citations to this article as recorded by
 Fournier’s Gangrene as an Adverse Event Following Treatment with Sodium Glucose Cotransporter 2 Inhibitors
Ioana-Maria Suciu, Alin Greluș, Alina-Ramona Cozlac, Bogdan-Simion Suciu, Svetlana Stoica, Silvia Luca, Constantin-Tudor Luca, Dan-Ion Gaiță
Medicina.2024; 60(5): 837. CrossRef A Case of Fournier's Gangrene Following the Initiation of Dapagliflozin
Natalie Shaykh, Avni Agrawal, Melville C O'Brien, Oshin Rai, Vanshika Tripathi, Vishal Jaikaransingh
Cureus.2024;[Epub] CrossRef Skin-Related Adverse Reactions Induced by Oral Antidiabetic Drugs—A Review of Literature and Case Reports
Justyna Kowalska, Dorota Wrześniok
Pharmaceuticals.2024; 17(7): 847. CrossRef Management of Fournier’s gangrene during the Covid-19 pandemic era: make a virtue out of necessity
Alessio Paladini, Giovanni Cochetti, Angelica Tancredi, Matteo Mearini, Andrea Vitale, Francesca Pastore, Paolo Mangione, Ettore Mearini
Basic and Clinical Andrology.2022;[Epub] CrossRef Dapagliflozin
Reactions Weekly.2022; 1926(1): 197. CrossRef
|